Psychotropic medications in mood disorders: to deprescribe or not?
In recent years deprescribing mood disorder medications has attracted increasing attention, and guidance provides suggestions for clinical implementation of deprescribing strategies that have been derived through expert consensus. Summarising and highlighting key recommendations, we discuss their execution in various clinical contexts and discuss their integration into clinical practice.
Authors
- Anne Naylor
- Erica Bell (ORCID: https://orcid.org/0000-0002-8483-8497)
- Gin S. Malhi (ORCID: https://orcid.org/0000-0002-4524-9091)
- Joseph F. Goldberg (ORCID: https://orcid.org/0000-0002-7160-7286)
- Steve Kisely (ORCID: https://orcid.org/0000-0003-4021-2924)
- Kinga Szymaniak (ORCID: https://orcid.org/0000-0001-5887-9028)
- Jeffrey CL Looi (ORCID: https://orcid.org/0000-0003-3351-6911)
- Gurubhaskar Shivakumar
Institutions
- Australian National University (AU)
- Dalhousie University (CA)
- The University of Queensland (AU)
- Royal North Shore Hospital (AU)
- Hornsby Ku-ring-gai Hospital (AU)
- North Shore Hospital (NZ)
- University of Oxford (GB)
- Princess Alexandra Hospital (GB)
- Institute of Aging (CA)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2026-09-14
- DOI
- https://doi.org/10.1192/bjp.2026.10779
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00